The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hormonal Transdermal Patches Market Research Report 2024
Synopsis
The global Hormonal Transdermal Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hormonal Transdermal Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hormonal Transdermal Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hormonal Transdermal Patches include Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hormonal Transdermal Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Transdermal Patches.
Report Scope
The Hormonal Transdermal Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormonal Transdermal Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals
Segment by Type
Contraceptive Patches
Estradiol Patches
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hormonal Transdermal Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hormonal Transdermal Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hormonal Transdermal Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hormonal Transdermal Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hormonal Transdermal Patches include Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hormonal Transdermal Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Transdermal Patches.
Report Scope
The Hormonal Transdermal Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormonal Transdermal Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals
Segment by Type
Contraceptive Patches
Estradiol Patches
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hormonal Transdermal Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hormonal Transdermal Patches Market Overview
1.1 Product Overview and Scope of Hormonal Transdermal Patches
1.2 Hormonal Transdermal Patches Segment by Type
1.2.1 Global Hormonal Transdermal Patches Market Value Comparison by Type (2024-2030)
1.2.2 Contraceptive Patches
1.2.3 Estradiol Patches
1.2.4 Others
1.3 Hormonal Transdermal Patches Segment by Application
1.3.1 Global Hormonal Transdermal Patches Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Hormonal Transdermal Patches Market Size Estimates and Forecasts
1.4.1 Global Hormonal Transdermal Patches Revenue 2019-2030
1.4.2 Global Hormonal Transdermal Patches Sales 2019-2030
1.4.3 Global Hormonal Transdermal Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hormonal Transdermal Patches Market Competition by Manufacturers
2.1 Global Hormonal Transdermal Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hormonal Transdermal Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hormonal Transdermal Patches Average Price by Manufacturers (2019-2024)
2.4 Global Hormonal Transdermal Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormonal Transdermal Patches, Product Type & Application
2.7 Hormonal Transdermal Patches Market Competitive Situation and Trends
2.7.1 Hormonal Transdermal Patches Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hormonal Transdermal Patches Players Market Share by Revenue
2.7.3 Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hormonal Transdermal Patches Retrospective Market Scenario by Region
3.1 Global Hormonal Transdermal Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hormonal Transdermal Patches Global Hormonal Transdermal Patches Sales by Region: 2019-2030
3.2.1 Global Hormonal Transdermal Patches Sales by Region: 2019-2024
3.2.2 Global Hormonal Transdermal Patches Sales by Region: 2025-2030
3.3 Global Hormonal Transdermal Patches Global Hormonal Transdermal Patches Revenue by Region: 2019-2030
3.3.1 Global Hormonal Transdermal Patches Revenue by Region: 2019-2024
3.3.2 Global Hormonal Transdermal Patches Revenue by Region: 2025-2030
3.4 North America Hormonal Transdermal Patches Market Facts & Figures by Country
3.4.1 North America Hormonal Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hormonal Transdermal Patches Sales by Country (2019-2030)
3.4.3 North America Hormonal Transdermal Patches Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hormonal Transdermal Patches Market Facts & Figures by Country
3.5.1 Europe Hormonal Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hormonal Transdermal Patches Sales by Country (2019-2030)
3.5.3 Europe Hormonal Transdermal Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormonal Transdermal Patches Market Facts & Figures by Country
3.6.1 Asia Pacific Hormonal Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hormonal Transdermal Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Hormonal Transdermal Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hormonal Transdermal Patches Market Facts & Figures by Country
3.7.1 Latin America Hormonal Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hormonal Transdermal Patches Sales by Country (2019-2030)
3.7.3 Latin America Hormonal Transdermal Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormonal Transdermal Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Hormonal Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hormonal Transdermal Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hormonal Transdermal Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hormonal Transdermal Patches Sales by Type (2019-2030)
4.1.1 Global Hormonal Transdermal Patches Sales by Type (2019-2024)
4.1.2 Global Hormonal Transdermal Patches Sales by Type (2025-2030)
4.1.3 Global Hormonal Transdermal Patches Sales Market Share by Type (2019-2030)
4.2 Global Hormonal Transdermal Patches Revenue by Type (2019-2030)
4.2.1 Global Hormonal Transdermal Patches Revenue by Type (2019-2024)
4.2.2 Global Hormonal Transdermal Patches Revenue by Type (2025-2030)
4.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Type (2019-2030)
4.3 Global Hormonal Transdermal Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hormonal Transdermal Patches Sales by Application (2019-2030)
5.1.1 Global Hormonal Transdermal Patches Sales by Application (2019-2024)
5.1.2 Global Hormonal Transdermal Patches Sales by Application (2025-2030)
5.1.3 Global Hormonal Transdermal Patches Sales Market Share by Application (2019-2030)
5.2 Global Hormonal Transdermal Patches Revenue by Application (2019-2030)
5.2.1 Global Hormonal Transdermal Patches Revenue by Application (2019-2024)
5.2.2 Global Hormonal Transdermal Patches Revenue by Application (2025-2030)
5.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Application (2019-2030)
5.3 Global Hormonal Transdermal Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Xulane
6.1.1 Xulane Corporation Information
6.1.2 Xulane Description and Business Overview
6.1.3 Xulane Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Xulane Hormonal Transdermal Patches Product Portfolio
6.1.5 Xulane Recent Developments/Updates
6.2 Twirla
6.2.1 Twirla Corporation Information
6.2.2 Twirla Description and Business Overview
6.2.3 Twirla Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Twirla Hormonal Transdermal Patches Product Portfolio
6.2.5 Twirla Recent Developments/Updates
6.3 Planned Parenthood
6.3.1 Planned Parenthood Corporation Information
6.3.2 Planned Parenthood Description and Business Overview
6.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Planned Parenthood Hormonal Transdermal Patches Product Portfolio
6.3.5 Planned Parenthood Recent Developments/Updates
6.4 Lvye Pharma
6.4.1 Lvye Pharma Corporation Information
6.4.2 Lvye Pharma Description and Business Overview
6.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lvye Pharma Hormonal Transdermal Patches Product Portfolio
6.4.5 Lvye Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Hormonal Transdermal Patches Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Bayer Healthcare Pharmaceuticals
6.6.1 Bayer Healthcare Pharmaceuticals Corporation Information
6.6.2 Bayer Healthcare Pharmaceuticals Description and Business Overview
6.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Portfolio
6.6.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
6.7 Watson Labs
6.6.1 Watson Labs Corporation Information
6.6.2 Watson Labs Description and Business Overview
6.6.3 Watson Labs Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Watson Labs Hormonal Transdermal Patches Product Portfolio
6.7.5 Watson Labs Recent Developments/Updates
6.8 Women First Healthcare Inc
6.8.1 Women First Healthcare Inc Corporation Information
6.8.2 Women First Healthcare Inc Description and Business Overview
6.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Product Portfolio
6.8.5 Women First Healthcare Inc Recent Developments/Updates
6.9 Noven
6.9.1 Noven Corporation Information
6.9.2 Noven Description and Business Overview
6.9.3 Noven Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Noven Hormonal Transdermal Patches Product Portfolio
6.9.5 Noven Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Corporation Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AbbVie Hormonal Transdermal Patches Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Lumara Health
6.11.1 Lumara Health Corporation Information
6.11.2 Lumara Health Hormonal Transdermal Patches Description and Business Overview
6.11.3 Lumara Health Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lumara Health Hormonal Transdermal Patches Product Portfolio
6.11.5 Lumara Health Recent Developments/Updates
6.12 ANI Pharmaceuticals
6.12.1 ANI Pharmaceuticals Corporation Information
6.12.2 ANI Pharmaceuticals Hormonal Transdermal Patches Description and Business Overview
6.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Product Portfolio
6.12.5 ANI Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormonal Transdermal Patches Industry Chain Analysis
7.2 Hormonal Transdermal Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormonal Transdermal Patches Production Mode & Process
7.4 Hormonal Transdermal Patches Sales and Marketing
7.4.1 Hormonal Transdermal Patches Sales Channels
7.4.2 Hormonal Transdermal Patches Distributors
7.5 Hormonal Transdermal Patches Customers
8 Hormonal Transdermal Patches Market Dynamics
8.1 Hormonal Transdermal Patches Industry Trends
8.2 Hormonal Transdermal Patches Market Drivers
8.3 Hormonal Transdermal Patches Market Challenges
8.4 Hormonal Transdermal Patches Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hormonal Transdermal Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hormonal Transdermal Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hormonal Transdermal Patches Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hormonal Transdermal Patches Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hormonal Transdermal Patches Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hormonal Transdermal Patches Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hormonal Transdermal Patches Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hormonal Transdermal Patches Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hormonal Transdermal Patches, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hormonal Transdermal Patches, Product Type & Application
Table 12. Global Key Manufacturers of Hormonal Transdermal Patches, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hormonal Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Transdermal Patches as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hormonal Transdermal Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hormonal Transdermal Patches Sales by Region (2019-2024) & (K Units)
Table 18. Global Hormonal Transdermal Patches Sales Market Share by Region (2019-2024)
Table 19. Global Hormonal Transdermal Patches Sales by Region (2025-2030) & (K Units)
Table 20. Global Hormonal Transdermal Patches Sales Market Share by Region (2025-2030)
Table 21. Global Hormonal Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hormonal Transdermal Patches Revenue Market Share by Region (2019-2024)
Table 23. Global Hormonal Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hormonal Transdermal Patches Revenue Market Share by Region (2025-2030)
Table 25. North America Hormonal Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hormonal Transdermal Patches Sales by Country (2019-2024) & (K Units)
Table 27. North America Hormonal Transdermal Patches Sales by Country (2025-2030) & (K Units)
Table 28. North America Hormonal Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hormonal Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hormonal Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hormonal Transdermal Patches Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hormonal Transdermal Patches Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hormonal Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hormonal Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hormonal Transdermal Patches Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hormonal Transdermal Patches Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hormonal Transdermal Patches Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hormonal Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hormonal Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hormonal Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hormonal Transdermal Patches Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hormonal Transdermal Patches Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hormonal Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hormonal Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hormonal Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hormonal Transdermal Patches Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hormonal Transdermal Patches Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hormonal Transdermal Patches Sales (K Units) by Type (2019-2024)
Table 51. Global Hormonal Transdermal Patches Sales (K Units) by Type (2025-2030)
Table 52. Global Hormonal Transdermal Patches Sales Market Share by Type (2019-2024)
Table 53. Global Hormonal Transdermal Patches Sales Market Share by Type (2025-2030)
Table 54. Global Hormonal Transdermal Patches Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hormonal Transdermal Patches Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hormonal Transdermal Patches Revenue Market Share by Type (2019-2024)
Table 57. Global Hormonal Transdermal Patches Revenue Market Share by Type (2025-2030)
Table 58. Global Hormonal Transdermal Patches Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hormonal Transdermal Patches Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hormonal Transdermal Patches Sales (K Units) by Application (2019-2024)
Table 61. Global Hormonal Transdermal Patches Sales (K Units) by Application (2025-2030)
Table 62. Global Hormonal Transdermal Patches Sales Market Share by Application (2019-2024)
Table 63. Global Hormonal Transdermal Patches Sales Market Share by Application (2025-2030)
Table 64. Global Hormonal Transdermal Patches Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hormonal Transdermal Patches Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hormonal Transdermal Patches Revenue Market Share by Application (2019-2024)
Table 67. Global Hormonal Transdermal Patches Revenue Market Share by Application (2025-2030)
Table 68. Global Hormonal Transdermal Patches Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hormonal Transdermal Patches Price (US$/Unit) by Application (2025-2030)
Table 70. Xulane Corporation Information
Table 71. Xulane Description and Business Overview
Table 72. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Xulane Hormonal Transdermal Patches Product
Table 74. Xulane Recent Developments/Updates
Table 75. Twirla Corporation Information
Table 76. Twirla Description and Business Overview
Table 77. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Twirla Hormonal Transdermal Patches Product
Table 79. Twirla Recent Developments/Updates
Table 80. Planned Parenthood Corporation Information
Table 81. Planned Parenthood Description and Business Overview
Table 82. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Planned Parenthood Hormonal Transdermal Patches Product
Table 84. Planned Parenthood Recent Developments/Updates
Table 85. Lvye Pharma Corporation Information
Table 86. Lvye Pharma Description and Business Overview
Table 87. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Lvye Pharma Hormonal Transdermal Patches Product
Table 89. Lvye Pharma Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Hormonal Transdermal Patches Product
Table 94. Novartis Recent Developments/Updates
Table 95. Bayer Healthcare Pharmaceuticals Corporation Information
Table 96. Bayer Healthcare Pharmaceuticals Description and Business Overview
Table 97. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product
Table 99. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
Table 100. Watson Labs Corporation Information
Table 101. Watson Labs Description and Business Overview
Table 102. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Watson Labs Hormonal Transdermal Patches Product
Table 104. Watson Labs Recent Developments/Updates
Table 105. Women First Healthcare Inc Corporation Information
Table 106. Women First Healthcare Inc Description and Business Overview
Table 107. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Women First Healthcare Inc Hormonal Transdermal Patches Product
Table 109. Women First Healthcare Inc Recent Developments/Updates
Table 110. Noven Corporation Information
Table 111. Noven Description and Business Overview
Table 112. Noven Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Noven Hormonal Transdermal Patches Product
Table 114. Noven Recent Developments/Updates
Table 115. AbbVie Corporation Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. AbbVie Hormonal Transdermal Patches Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Lumara Health Corporation Information
Table 121. Lumara Health Description and Business Overview
Table 122. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Lumara Health Hormonal Transdermal Patches Product
Table 124. Lumara Health Recent Developments/Updates
Table 125. ANI Pharmaceuticals Corporation Information
Table 126. ANI Pharmaceuticals Description and Business Overview
Table 127. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. ANI Pharmaceuticals Hormonal Transdermal Patches Product
Table 129. ANI Pharmaceuticals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Hormonal Transdermal Patches Distributors List
Table 133. Hormonal Transdermal Patches Customers List
Table 134. Hormonal Transdermal Patches Market Trends
Table 135. Hormonal Transdermal Patches Market Drivers
Table 136. Hormonal Transdermal Patches Market Challenges
Table 137. Hormonal Transdermal Patches Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hormonal Transdermal Patches
Figure 2. Global Hormonal Transdermal Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hormonal Transdermal Patches Market Share by Type in 2023 & 2030
Figure 4. Contraceptive Patches Product Picture
Figure 5. Estradiol Patches Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hormonal Transdermal Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hormonal Transdermal Patches Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Hormonal Transdermal Patches Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Hormonal Transdermal Patches Market Size (2019-2030) & (US$ Million)
Figure 13. Global Hormonal Transdermal Patches Sales (2019-2030) & (K Units)
Figure 14. Global Hormonal Transdermal Patches Average Price (US$/Unit) & (2019-2030)
Figure 15. Hormonal Transdermal Patches Report Years Considered
Figure 16. Hormonal Transdermal Patches Sales Share by Manufacturers in 2023
Figure 17. Global Hormonal Transdermal Patches Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Hormonal Transdermal Patches Players: Market Share by Revenue in 2023
Figure 19. Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Hormonal Transdermal Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Hormonal Transdermal Patches Sales Market Share by Country (2019-2030)
Figure 22. North America Hormonal Transdermal Patches Revenue Market Share by Country (2019-2030)
Figure 23. United States Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Hormonal Transdermal Patches Sales Market Share by Country (2019-2030)
Figure 26. Europe Hormonal Transdermal Patches Revenue Market Share by Country (2019-2030)
Figure 27. Germany Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Hormonal Transdermal Patches Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Hormonal Transdermal Patches Revenue Market Share by Region (2019-2030)
Figure 34. China Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Hormonal Transdermal Patches Sales Market Share by Country (2019-2030)
Figure 44. Latin America Hormonal Transdermal Patches Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Hormonal Transdermal Patches Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Hormonal Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Hormonal Transdermal Patches by Type (2019-2030)
Figure 54. Global Revenue Market Share of Hormonal Transdermal Patches by Type (2019-2030)
Figure 55. Global Hormonal Transdermal Patches Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Hormonal Transdermal Patches by Application (2019-2030)
Figure 57. Global Revenue Market Share of Hormonal Transdermal Patches by Application (2019-2030)
Figure 58. Global Hormonal Transdermal Patches Price (US$/Unit) by Application (2019-2030)
Figure 59. Hormonal Transdermal Patches Value Chain
Figure 60. Hormonal Transdermal Patches Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
